Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem

Bibliographic Details
Main Authors: Natalia G. Vallianou, Gerasimos Socrates Christodoulatos, Dimitris Kounatidis, Maria Dalamaga
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Metabolism Open
Subjects:
Cardiovascular disease
Diabetes
Heart failure
Sodium glucose co-transporters inhibitor
Sotagliflozin
Online Access:http://www.sciencedirect.com/science/article/pii/S258993682100013X
id doaj-28ee0b9d91b1414790d80cf5f2dedb89
record_format Article
spelling doaj-28ee0b9d91b1414790d80cf5f2dedb892021-06-15T04:15:07ZengElsevierMetabolism Open2589-93682021-06-0110100089Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problemNatalia G. Vallianou0Gerasimos Socrates Christodoulatos1Dimitris Kounatidis2Maria Dalamaga3First Department of Internal Medicine, Evangelismos General Hospital, 45-47 Ipsilantou Str, 10676, Athens, GreeceDepartment of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Str, Goudi, 11527, Athens, GreeceFirst Department of Internal Medicine, Evangelismos General Hospital, 45-47 Ipsilantou Str, 10676, Athens, GreeceCorresponding author. Biological Chemistry-Clinical Biochemistry, National and Kapodistrian University of Athens, Medical School, Mikras Asias #27, Goudi, 11527, Athens, Greece.; Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Str, Goudi, 11527, Athens, Greecehttp://www.sciencedirect.com/science/article/pii/S258993682100013XCardiovascular diseaseDiabetesHeart failureSodium glucose co-transporters inhibitorSotagliflozin
collection DOAJ
language English
format Article
sources DOAJ
author Natalia G. Vallianou
Gerasimos Socrates Christodoulatos
Dimitris Kounatidis
Maria Dalamaga
spellingShingle Natalia G. Vallianou
Gerasimos Socrates Christodoulatos
Dimitris Kounatidis
Maria Dalamaga
Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem
Metabolism Open
Cardiovascular disease
Diabetes
Heart failure
Sodium glucose co-transporters inhibitor
Sotagliflozin
author_facet Natalia G. Vallianou
Gerasimos Socrates Christodoulatos
Dimitris Kounatidis
Maria Dalamaga
author_sort Natalia G. Vallianou
title Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem
title_short Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem
title_full Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem
title_fullStr Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem
title_full_unstemmed Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem
title_sort sotagliflozin, a dual sglt1 and sglt2 inhibitor: in the heart of the problem
publisher Elsevier
series Metabolism Open
issn 2589-9368
publishDate 2021-06-01
topic Cardiovascular disease
Diabetes
Heart failure
Sodium glucose co-transporters inhibitor
Sotagliflozin
url http://www.sciencedirect.com/science/article/pii/S258993682100013X
work_keys_str_mv AT nataliagvallianou sotagliflozinadualsglt1andsglt2inhibitorintheheartoftheproblem
AT gerasimossocrateschristodoulatos sotagliflozinadualsglt1andsglt2inhibitorintheheartoftheproblem
AT dimitriskounatidis sotagliflozinadualsglt1andsglt2inhibitorintheheartoftheproblem
AT mariadalamaga sotagliflozinadualsglt1andsglt2inhibitorintheheartoftheproblem
_version_ 1721377535590137856

Similar Items